Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics

The utilized 3D printhead employs an innovative hot-melt extrusion (HME) design approach being fed by drug-loaded polymer granules and making filament strands obsolete. Oscillatory rheology is a key tool for understanding the behavior of a polymer melt in extrusion processes. In this study, small am...

Full description

Bibliographic Details
Main Authors: Thomas Pflieger, Rakesh Venkatesh, Markus Dachtler, Karin Eggenreich, Stefan Laufer, Dominique Lunter
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/11/2488
_version_ 1797464259496509440
author Thomas Pflieger
Rakesh Venkatesh
Markus Dachtler
Karin Eggenreich
Stefan Laufer
Dominique Lunter
author_facet Thomas Pflieger
Rakesh Venkatesh
Markus Dachtler
Karin Eggenreich
Stefan Laufer
Dominique Lunter
author_sort Thomas Pflieger
collection DOAJ
description The utilized 3D printhead employs an innovative hot-melt extrusion (HME) design approach being fed by drug-loaded polymer granules and making filament strands obsolete. Oscillatory rheology is a key tool for understanding the behavior of a polymer melt in extrusion processes. In this study, small amplitude shear oscillatory (SAOS) rheology was applied to investigate formulations of model antihypertensive drug Metoprolol Succinate (MSN) in two carrier polymers for pharmaceutical three-dimensional printing (3DP). For a standardized printing process, the feeding polymers viscosity results were correlated to their printability and a better understanding of the 3DP extrudability of a pharmaceutical formulation was developed. It was found that the printing temperature is of fundamental importance, although it is limited by process parameters and the decomposition of the active pharmaceutical ingredients (API). Material characterization including differential scanning calorimetry (DSC) and thermogravimetric analyses (TGA) of the formulations were performed to evaluate component miscibility and ensure thermal durability. To assure the development of a printing process eligible for approval, all print runs were investigated for uniformity of mass and uniformity of dosage in accordance with the European Pharmacopoeia (Ph. Eur.).
first_indexed 2024-03-09T18:04:57Z
format Article
id doaj.art-f3c01b12b2b9410dbd1688d5812faa38
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T18:04:57Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-f3c01b12b2b9410dbd1688d5812faa382023-11-24T09:36:38ZengMDPI AGPharmaceutics1999-49232022-11-011411248810.3390/pharmaceutics14112488Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product CharacteristicsThomas Pflieger0Rakesh Venkatesh1Markus Dachtler2Karin Eggenreich3Stefan Laufer4Dominique Lunter5Digital Health Systems GmbH (DiHeSys), 73529 Schwaebisch Gmuend, GermanyDigital Health Systems GmbH (DiHeSys), 73529 Schwaebisch Gmuend, GermanyDigital Health Systems GmbH (DiHeSys), 73529 Schwaebisch Gmuend, GermanyGen-Plus GmbH & Co., KG, 81477 Munich, GermanyPharmaceutical Chemistry, Eberhard Karls University, 72074 Tuebingen, GermanyPharmaceutical Technology, Eberhard Karls University, 72074 Tuebingen, GermanyThe utilized 3D printhead employs an innovative hot-melt extrusion (HME) design approach being fed by drug-loaded polymer granules and making filament strands obsolete. Oscillatory rheology is a key tool for understanding the behavior of a polymer melt in extrusion processes. In this study, small amplitude shear oscillatory (SAOS) rheology was applied to investigate formulations of model antihypertensive drug Metoprolol Succinate (MSN) in two carrier polymers for pharmaceutical three-dimensional printing (3DP). For a standardized printing process, the feeding polymers viscosity results were correlated to their printability and a better understanding of the 3DP extrudability of a pharmaceutical formulation was developed. It was found that the printing temperature is of fundamental importance, although it is limited by process parameters and the decomposition of the active pharmaceutical ingredients (API). Material characterization including differential scanning calorimetry (DSC) and thermogravimetric analyses (TGA) of the formulations were performed to evaluate component miscibility and ensure thermal durability. To assure the development of a printing process eligible for approval, all print runs were investigated for uniformity of mass and uniformity of dosage in accordance with the European Pharmacopoeia (Ph. Eur.).https://www.mdpi.com/1999-4923/14/11/2488pharmaceutical three-dimensional printing (3DP)hot-melt extrusion (HME)printabilityoscillatory rheologynovel printhead design
spellingShingle Thomas Pflieger
Rakesh Venkatesh
Markus Dachtler
Karin Eggenreich
Stefan Laufer
Dominique Lunter
Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
Pharmaceutics
pharmaceutical three-dimensional printing (3DP)
hot-melt extrusion (HME)
printability
oscillatory rheology
novel printhead design
title Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
title_full Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
title_fullStr Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
title_full_unstemmed Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
title_short Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
title_sort novel approach to pharmaceutical 3d printing omitting the need for filament investigation of materials process and product characteristics
topic pharmaceutical three-dimensional printing (3DP)
hot-melt extrusion (HME)
printability
oscillatory rheology
novel printhead design
url https://www.mdpi.com/1999-4923/14/11/2488
work_keys_str_mv AT thomaspflieger novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics
AT rakeshvenkatesh novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics
AT markusdachtler novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics
AT karineggenreich novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics
AT stefanlaufer novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics
AT dominiquelunter novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics